AbCellera Biologics Inc.
ABCL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001703057
In the last 90 days, AbCellera Biologics Inc. insiders filed 4 open-market purchases and 0 sales; 150 institutions reported holding it in 13F filings for Q2 2026, worth $908.8M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding AbCellera Biologics Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 130 | 2 | 162 | +34 |
| Shares | 113.5M | 1.47M | 118.1M | +6.13M (+5.5%) |
| Value | $1.10B | $14.4M | $1.26B | +$174.2M (+16.0%) |
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (55)
Institutions that held AbCellera Biologics Inc. at the end of Q2 2022 but not at the end of Q1 2022.
Sold out (21)
Institutions that held AbCellera Biologics Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| SB Management Ltd | 7,764,299 | $75.7M |
| Capital International Investors | 2,626,644 | $25.6M |
| Qube Research & Technologies Ltd | 149,417 | $1.46M |
| Woodline Partners LP | 136,910 | $1.33M |
| Susquehanna International Group, LLP | 128,512 | $1.25M |
| HRT Financial LP | 62,568 | $610.0K |
| Balyasny Asset Management LLC | 62,339 | $608.0K |
| Paloma Partners Management Co | 61,587 | $600.0K |
| Janney Montgomery Scott LLC | 53,261 | $519.0K |
| Y-Intercept (Hong Kong) Ltd | 46,355 | $452.0K |
| Blueshift Asset Management, LLC | 32,574 | $318.0K |
| Dynamic Technology Lab Private Ltd | 31,427 | $306.0K |
| Fox Run Management, L.L.C. | 24,366 | $238.0K |
| Belvedere Trading LLC | 19,810 | $172.0K |
| CTC Capital Management, LLC | 16,000 | $156.0K |
| SG3 Management, LLC | 5,000 | $49.0K |
| Cutler Group LP | 2,200 | $21.0K |
| Evoke Wealth, LLC | 1,200 | $12.0K |
| Beaird Harris Wealth Management, LLC | 600 | $6.00K |
| Robbins Farley LLC | 500 | $5.00K |
| JCIC Asset Management Inc. | 25 | $0 |
Not filed for Q2 2022 yet (2)
Institutions that held AbCellera Biologics Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 1,150,000 | $11.2M |
| Susquehanna Fundamental Investments, LLC | 322,856 | $3.15M |